Capital Fund Management (CFM)
PCRX icon

Capital Fund Management (CFM)’s Pacira BioSciences PCRX Stock Holding History

Capital Fund Management (CFM)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-175,225
Closed -$3.3M – 2268
2024
Q4 		$3.3M Buy
175,225
+45,016
+35% +$790K 0.01% 1281
2024
Q3 		$1.96M Buy
+130,209
New +$2.23M 0.01% 1443
2021
Q1 		– Sell
-70,827
Closed -$4.24M – 1539
2020
Q4 		$4.24M Buy
70,827
+47,504
+204% +$2.78M 0.04% 524
2020
Q3 		$1.4M Buy
23,323
+311
+1% +$18.1K 0.02% 762
2020
Q2 		$1.21M Sell
23,012
-13,627
-37% -$570K 0.02% 642
2020
Q1 		$1.23M Buy
36,639
+8,903
+32% +$370K 0.02% 705
2019
Q4 		$1.26M Buy
+27,736
New +$1.18M 0.01% 1008
2019
Q1 		– Sell
-66,122
Closed -$2.85M – 1997
2018
Q4 		$2.85M Buy
66,122
+44,000
+199% +$2.05M 0.03% 711
2018
Q3 		$1.09M Buy
22,122
+15,632
+241% +$676K 0.01% 1338
2018
Q2 		$208K Sell
6,490
-211
-3% -$7.29K ﹤0.01% 1900
2018
Q1 		$209K Buy
+6,701
New +$239K ﹤0.01% 1755
2017
Q3 		– Sell
-5,351
Closed -$255K – 1689
2017
Q2 		$255K Sell
5,351
-1,236
-19% -$57.3K ﹤0.01% 1324
2017
Q1 		$300K Buy
+6,587
New +$285K ﹤0.01% 1290
2016
Q4 		– Sell
-38,346
Closed -$1.31M – 1809
2016
Q3 		$1.31M Buy
+38,346
New +$1.5M 0.01% 883
2015
Q2 		– Sell
-76,297
Closed -$6.78M – 1658
2015
Q1 		$6.78M Sell
76,297
-5,800
-7% -$588K 0.09% 266
2014
Q4 		$7.28M Buy
+82,097
New +$7.77M 0.09% 321

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Capital Fund Management (CFM)'s PCRX Position: Q1 2025 in Review

Capital Fund Management (CFM) sold out of Pacira BioSciences (PCRX) in Q1 2025, closing a stake of 175,225 shares — an estimated $3.3M sold.

Capital Fund Management (CFM) first reported a position in PCRX in Q4 2014 and held it in 16 quarters. The position peaked at $7.28M in Q4 2014. 235 funds tracked by Wall St. Rank hold PCRX as of Q1 2025.

  • Capital Fund Management (CFM) reported no remaining Pacira BioSciences position as of Q1 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 175,225 Pacira BioSciences shares in Q1 2025, an estimated $3.3M.
  • Capital Fund Management (CFM) first reported a position in Pacira BioSciences in Q4 2014 and held it in 16 quarters.
  • Capital Fund Management (CFM)'s Pacira BioSciences position peaked at $7.28M in Q4 2014.
  • 235 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2025, filed 14 May 2025.